Lecture: Immunosuppressive TX Flashcards

1
Q

Most immunosuppressive agents have a …….

A

lag phase before reaching full efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

immunosuppressive guidelines (carefully monitor…..)

A
  • careful monitoring of CBC and platelet counts during therapy
  • antibiotic therapy necessary in the first few months of therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

If worsening of skin lesions with steroids, consider:_____

before increasing dose

A
  • demodecosis
  • dermatophytosis
  • bacterial infection
  • calcinosis cutis (dogs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

After relapse of autoimmune dz …..

A

resistance to previously used glucocorticoids may be observed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

most animals require therapy for

A

life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DLE (discoid lupus erythematous) and PE usually managed with

A
  • topical glucocorticoid
  • topical tacrolimus
  • tetracycline and niacinamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PF usually requires a combo of

A

glucocorticoids and another immunosuppressive agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PV and BP usually require

A

very high doses that are rarely tolerated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

High dose steroids can kill a patient due to

A

GI ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SLE usually requires combo of

A
  • glucocorticoids and another immunosuppressive agent

*Gold salts are contraindicated due to potential for renal toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Glucocorticoids

A
  • used for management of autoimmune diseases due to anti-inflammatory properties
    • inhibits macrophages chemotaxis
    • Phospholipase A2
    • Reduce compliment levels
    • Decrease capillary permeability
    • Inhibit PMN chemotaxis and phagocytosis
    • Stabilize lysosomal membranes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Rules for steroid therapy

A
  • oral steroids
  • alternate days to minimize adrenal suppression
    • prednisone
    • prednisolone
    • methylprednisolone
  • use lowest effective dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Induction of steroid therapy

A
  • lasts 10-14 days
  • once no new lesions, tapering is started
  • maintenance dose achieved in 8-10 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prednisone

immunosuppressive doses

A
  • Dogs
    • induction: 2.2-3.3 mg/kg q 12hr
    • maintenance: 0.5-1 mg/kg q 48hr
  • Cats
    • induction: 3.3-4.4 mg/kg q 12hr
    • maintenance: 1-2 mg/kg q 48hr
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Immunosuppressive doses

Methylprednisolone

A
  • Dogs
    • Induction: 0.8-1.5 mg/kg q 12hrs
    • Maintenance: 0.3-0.8 mg/kg q 48hrs
  • Cats
    • Induction: 1.5-3 mg/kg q 12hrs
    • Maintenance: 0.6-1.5 mg/kg q 48hrs

*Less PUPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Immunosuppressive doses

dexamethasone

A
  • Dogs
    • Induction: 0.1-0.2 mg/kg q 12hrs
    • maintenance: 0.05-0.1 mg/kg q 48-72hrs
  • Cats
    • Induction: 0.2-0.4 mg/kg q 12hrs
    • Maintenance: 0.1-0.2 mg/kg q 48-72hrs
17
Q

Side effects of steroid therapy

A
  • GI ulcers
  • PU/PD
  • Polyphagia
  • Panting
  • Behavioral changes
  • Diabetes
  • Steroid hepatopathy
18
Q

Other side effect of steroid therapy

A
  • Muscle weakness
  • Osteoporosis
  • Redistribution of body fat
  • Decreased synthesis of thyroid hormones
  • Inc risk of infections
    • skin
    • urinary tract
19
Q

Side effects on skin of steroid therapy

A
  • thin skin
  • comedones
  • demodicosis
  • calcinosis cutis (dogs)
  • skin fragility (cats)
20
Q

Azathioprine metabolism

A
  • TPMT deficiency leads to inc production of active metabolites => inc toxicity
  • Some dogs have genetic deficiency in TPMT
21
Q

Side effects of Azathioprine

A
  • bone marrow suppression
    • anemia
    • leukopenia
    • Thrombocytopenia
  • pancreatitis
  • Hepatitis
  • Vomiting
  • Hemorrhagic diarrhea
22
Q

Azathioprine

A
  • 2.2 mg/kg q 48hrs (50 mg tab)
  • Lag phase of 4-6 weeks
  • Dose should be reduced when used with xanthine oxidase inhibitor
  • monitor CBC and platelet counts q 2 weeks
  • DO NOT USE IN CATS
23
Q

Chlorambucil

A
  • used for cats
  • Cytotoxic
  • alkylating agent: causes DNA breaks and cross-links
  • Toxic for B cells
  • Lag phase
  • Liver metabolism
  • bone marrow suppression
  • V/D
24
Q

Chlorambucil

Dose

A
  • 0.1-0.2 mg/kg q 48hrs (2 mg tab)
  • Lag phase: 6 weeks
  • monitor CBC and platelet counts q 2 weeks
  • Safe for cats
25
Gold salts
* injectible * 1 mg/kg IM q 1 week until remission * lag phase 6-12 weeks * side effects * bone marrow suppression * nephrotoxicity * hepatic necrosis * drug eruption (EM, TEN) * **don't use for dogs**
26
27
28
Cyclophosphamide
* alkylating agent * Interference with DNA replication * side effects * bone marrow suppression * **hemorrhagic cystitis** * bladder fibrosis * teratogenesis
29
Tetracycline and Niacinamide together
* Dosing regimen is 3 X a day * Tetracycline * inhibits PMN chemotaxis * Inhibits complement and PG synthesis * Niacinamide * Inhibits mast cell degranulation * Inhibits PDE thus stabilizes cells
30
Tetracycline and Niacinamide doses
* dogs \> 10 kg : 500 mg each TID * Dogs \< 10 kg : 250 mg each TID \*70% effective for DLE \*15% effective for PF * Adverse effects * V/D * anorexia * inc liver enzymes * seizures
31
Cyclosporine
* Adjunctive therapy * dec nec dose of glucocorticoids * suppresses T cell proliferation and activation * metabolized by cytochrome P450 * delayed metabolism in patients with liver dz
32
Cyclosporine doses
* Induction: 20 mg/kg a 24 hrs * Maintenance: 10 mg/kg q 48 hrs * as adjuctive therapy: 5 mg/kg SID to EOD
33
Cyclosporin adverse effects
* GI upset * nephrotoxicity * papillomatous dermatitis * gingival hyperplasia
34
Dapsone
* used in conjuction with glucocorticoids * lag phase 4-6 weeks * decreases * complement * antibody production * PMN chemotaxis * I mg/kg TID